357 related articles for article (PubMed ID: 8225488)
21. Characterization of naphtho[1,2-a]pyrene and naphtho[1,2-e]pyrene DNA adducts in C3H10T1/2 fibroblasts.
Nelson G; Ross JA; Pimentel M; Desai D; Sharma AK; Amin S; Nesnow S
Cancer Lett; 2007 Mar; 247(2):309-17. PubMed ID: 16814461
[TBL] [Abstract][Full Text] [Related]
22. Detection of DNA and globin adducts of polynuclear aromatic hydrocarbon diol epoxides by gas chromatography-mass spectrometry and -3H-CH3I postlabeling of released tetraols.
Melikian AA; Sun P; Coleman S; Amin S; Hecht SS
Chem Res Toxicol; 1996 Mar; 9(2):508-16. PubMed ID: 8839056
[TBL] [Abstract][Full Text] [Related]
23. Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides.
Melendez-Colon VJ; Smith CA; Seidel A; Luch A; Platt KL; Baird WM
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13542-7. PubMed ID: 9391062
[TBL] [Abstract][Full Text] [Related]
24. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers.
Perera FP; Hemminki K; Young TL; Brenner D; Kelly G; Santella RM
Cancer Res; 1988 Apr; 48(8):2288-91. PubMed ID: 3127049
[TBL] [Abstract][Full Text] [Related]
25. Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels.
Ross JA; Nelson GB; Wilson KH; Rabinowitz JR; Galati A; Stoner GD; Nesnow S; Mass MJ
Cancer Res; 1995 Mar; 55(5):1039-44. PubMed ID: 7866986
[TBL] [Abstract][Full Text] [Related]
26. Dosimeters of human exposure to carcinogens: polycyclic aromatic hydrocarbon-macromolecular adducts.
Weston A; Willey JC; Manchester DK; Wilson VL; Brooks BR; Choi JS; Poirier MC; Trivers GE; Newman MJ; Mann DL
IARC Sci Publ; 1988; (89):181-9. PubMed ID: 3143667
[TBL] [Abstract][Full Text] [Related]
27. Comparative in vitro metabolism of benzo[a]pyrene by recombinant zebrafish CYP1A and liver microsomes from beta-naphthoflavone-treated rainbow trout.
Miranda CL; Chung WG; Wang-Buhler JL; Musafia-Jeknic T; Baird WM; Buhler DR
Aquat Toxicol; 2006 Nov; 80(2):101-8. PubMed ID: 16963132
[TBL] [Abstract][Full Text] [Related]
28. Preparation, isolation, and characterization of Dibenzo[a,l]pyrene diol epoxide-deoxyribonucleoside monophosphate adducts by HPLC and fluorescence line-narrowing spectroscopy.
Devanesan P; Ariese F; Jankowiak R; Small GJ; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1999 Sep; 12(9):789-95. PubMed ID: 10490499
[TBL] [Abstract][Full Text] [Related]
29. Benzo(e)pyrene-induced alterations in the metabolic activation of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene by hamster embryo cells.
Baird WM; Salmon CP; Diamond L
Cancer Res; 1984 Apr; 44(4):1445-52. PubMed ID: 6322978
[TBL] [Abstract][Full Text] [Related]
30. Products of binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse skin.
Bigger CA; Sawicki JT; Blake DM; Raymond LG; Dipple A
Cancer Res; 1983 Dec; 43(12 Pt 1):5647-51. PubMed ID: 6315214
[TBL] [Abstract][Full Text] [Related]
31. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
32. Covalent binding of 7,12-dimethylbenz(a)anthracene and 10-fluoro-7,12-dimethylbenz(a)anthracene to mouse epidermal DNA and its relationship to tumor-initiating activity.
DiGiovanni J; Fisher EP; Aalfs KK; Prichett WP
Cancer Res; 1985 Feb; 45(2):591-7. PubMed ID: 3917851
[TBL] [Abstract][Full Text] [Related]
33. Optically active benzo[c]phenanthrene diol epoxides bind extensively to adenine in DNA.
Dipple A; Pigott MA; Agarwal SK; Yagi H; Sayer JM; Jerina DM
Nature; 1987 Jun 11-17; 327(6122):535-6. PubMed ID: 3587368
[TBL] [Abstract][Full Text] [Related]
34. Benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene metabolism and DNA adduct formation in primary cultures of hamster epidermal cells.
DiGiovanni J; Sina JF; Ashurst SW; Singer JM; Diamond L
Cancer Res; 1983 Jan; 43(1):163-70. PubMed ID: 6291752
[TBL] [Abstract][Full Text] [Related]
35. Separation of 32P-labelled nucleoside 3',5'-bisphosphate adducts by HPLC.
Pfau W; Lecoq S; Hughes NC; Seidel A; Platt KL; Grover PL; Phillips DH
IARC Sci Publ; 1993; (124):233-42. PubMed ID: 8225490
[TBL] [Abstract][Full Text] [Related]
36. Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts.
Day BW; Naylor S; Gan LS; Sahali Y; Nguyen TT; Skipper PL; Wishnok JS; Tannenbaum SR
Cancer Res; 1990 Aug; 50(15):4611-8. PubMed ID: 2369737
[TBL] [Abstract][Full Text] [Related]
37. Role of cytochrome p4501 family members in the metabolic activation of polycyclic aromatic hydrocarbons in mouse epidermis.
Kleiner HE; Vulimiri SV; Hatten WB; Reed MJ; Nebert DW; Jefcoate CR; DiGiovanni J
Chem Res Toxicol; 2004 Dec; 17(12):1667-74. PubMed ID: 15606143
[TBL] [Abstract][Full Text] [Related]
38. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
39. Relationship between mutagenicity and DNA adduct formation in mammalian cells for fjord- and bay-region diol-epoxides of polycyclic aromatic hydrocarbons.
Phillips DH; Hewer A; Seidel A; Steinbrecher T; Schrode R; Oesch F; Glatt H
Chem Biol Interact; 1991; 80(2):177-86. PubMed ID: 1934148
[TBL] [Abstract][Full Text] [Related]
40. 32P-postlabelling methods for cyclic DNA adducts.
Watson WP; Crane AE; Steiner S
IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
